Thyroid Function in Monozygotic Twins with Intra-twin Birth Weight Differences: A Prospective Longitudinal Cohort Study.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
08 2019
Historique:
received: 13 09 2018
revised: 01 03 2019
accepted: 26 03 2019
pubmed: 12 5 2019
medline: 14 4 2020
entrez: 12 5 2019
Statut: ppublish

Résumé

To analyze the long-term impact of birth weight (BW) on thyroid function in genetically identical twins with intra-twin BW differences from birth to adolescence. In total, 52 monozygotic twin pairs underwent at least one analysis of thyroid function at mean ages of 10.1 years (27 pairs), 15.1 years (35 pairs), and 17.4 years (36 pairs); 18 pairs donated blood at all time points. BW difference of <1 SDS was defined as concordant, BW difference ≥1 SDS as discordant. In concordant twins, no significant differences were observed. In the discordant group, smaller twins had higher mean thyroid-stimulating hormone (TSH) than their larger co-twins at 10.1 years (3.6 vs 2.5 μU/mL; P = .04) and 15.1 years (2.6 vs 2.2 μU/mL; P = .08). Smaller twins showed lower mean thyroxine than larger co-twins at 10.1 years (7.8 vs 8.2 μg/dL P = .05) and 17.4 years (7.7 vs 8.4 μg/dL; P = .03), and a tendency at 15.1 years (6.9 vs 7.4 μg/dL; P = .09). Calculation of TSH-thyroxine ratio revealed significant differences in the discordant group, with greater ratios in the smaller twin at 10.1 years (0.5 vs 0.3; P = .006) and 15.1 years (0.4 vs 0.3; P = .04). In this group of monozygotic twins with intra-twin BW differences, BW seemed to exert a long-lasting impact on thyroid function. This may be due to a delay in hypothalamic-pituitary-thyroid axis maturation, with TSH resistance during childhood and early adolescence in children with low BW.

Identifiants

pubmed: 31076228
pii: S0022-3476(19)30397-X
doi: 10.1016/j.jpeds.2019.03.041
pii:
doi:

Substances chimiques

Antibodies 0
Thyrotropin 9002-71-5
Thyroglobulin 9010-34-8
Iodide Peroxidase EC 1.11.1.8
Thyroxine Q51BO43MG4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-171.e4

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Sandra Schulte (S)

Department of Paediatric Endocrinology and Diabetology, Children's University Hospital Bonn, Bonn, Germany.

Bettina Gohlke (B)

Department of Paediatric Endocrinology and Diabetology, Children's University Hospital Bonn, Bonn, Germany. Electronic address: bettina-gohlke@t-online.de.

Felix Schreiner (F)

Department of Paediatric Endocrinology and Diabetology, Children's University Hospital Bonn, Bonn, Germany.

Mathias Gruenewald (M)

Department of Paediatric Endocrinology and Diabetology, Children's University Hospital Bonn, Bonn, Germany.

Rolf Fimmers (R)

Institute of Medical Biometry, Informatics and Epidemiology (IMBIE), University Hospital Bonn, Bonn, Germany.

Birgit Stoffel-Wagner (B)

Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.

Peter Bartmann (P)

Department of Neonatology, Children's University Hospital Bonn, Bonn, Germany.

Joachim Woelfle (J)

Department of Paediatric Endocrinology and Diabetology, Children's University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH